Loading company…
Cambridge, US-based developer of cancer immunotherapies that aim to enhance the immune system's response to tumors.
Surface Oncology, Inc. was founded in 2014 by John Stagg and is headquartered in Cambridge, US. The company develops cancer immunotherapies designed to harness the immune system against tumors. It has completed seven deals, the most recent an ADD-ON Trade Sale round led by Coherus Biosciences, Inc. on April 18, 2018 that raised USD 40.00 mn. Its total raised is USD 11.50 mn, and the company is at the Series A stage.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in